Dual therapy with corticosteroid ablates the beneficial effect of DP2 antagonism in chronic experimental asthma.
A. Ullah, S. Rittchen, J. Li, B. F. Curren, M. M. Rahman, M. A. A. Sikder, R. B. Rashid, N. Collinson, M. Lor, M. L. Smythe, S. Phipps
This study shows that combining DP2 antagonism with corticosteroids reduces the effectiveness of DP2 antagonism in treating chronic asthma by suppressing PGD2 and IFN-γ production.
bioRxiv · Nov 12, 2023Immunology